Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2010
03/10/2010EP2161020A1 Chelating amphiphilic polymers
03/10/2010EP2160200A1 Antibody-light fusion products for cancer therapeutics
03/10/2010EP2160185A1 Methods of making and using nano scale particles
03/10/2010EP2160183A1 Extended release formulations comprising quetipine and methods for their manufacture
03/10/2010EP2160182A1 Formulations and methods for treating dry eye
03/10/2010EP1768491B1 Composition and its use for controlling protozoal infections of animals
03/10/2010EP1713510B1 Growth factor-binding compounds attached to a calixarene
03/10/2010EP1660104B1 Pharmaceutical formulation comprising lanthanum compounds
03/10/2010EP1656410B1 Method for preparing functionalized polymers from polymer alcohols
03/10/2010EP1605964B1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE
03/10/2010EP0830146B1 Methods of inducing immune tolerance using immunotoxins
03/10/2010CN101668545A Fusion protein capable of degrading amyloid beta peptide
03/10/2010CN101668544A Preparation for transnasal application
03/10/2010CN101665538A Novel GLP-1 analogues linked to albumin-like agents
03/10/2010CN101664558A Chitosan-collagen-diprospan slow releasing system, preparation method and application thereof
03/10/2010CN101664557A Nano-hydrogel drug carrier material with photosensitivity and temperature sensibility
03/10/2010CN101664556A Lactose-polyvidone-crospolyvidone premixed agent and preparation method thereof
03/10/2010CN101664545A Therapies for renal failure using interferon-beta
03/10/2010CN101664414A Combination of brimonidine and timolol for topical ophthalmic use
03/10/2010CN101664388A transnasal transport/immunisation with highly adaptable carriers
03/10/2010CN100593420C Endostatin conjugate and its preparation method
03/10/2010CN100593398C Film-shaped, dissolvable preparations for active substance release and method for the production thereof
03/09/2010US7674883 Hybridoma cell line for production of transmembrane protein with EGF-like and 2 follistatin-like domains 2 specific immunoglobulin conjugate for diagnosis and treatment of prostate cancer
03/09/2010US7674879 Controlling hydrolysis stability of polymer; reacting polyether with n,n'-dicyclohexylcarbodiimide
03/09/2010US7674875 Star polymer such as of a polylactone based on a central phosphorus atom derived from phosphorus oxychloride (POCl3) or ethyl dichlorophosphate; biodegradable and/or biocompatible; sustained release drug delivery; reverse thermal gelation
03/09/2010US7674860 Redispersible powder and its aqueous dispersion, preparation, process and use
03/09/2010US7674790 Processes of making and using pharmaceutical formulations of antineoplastic agents
03/09/2010US7674777 Immunostimulatory nucleic acid molecules
03/09/2010US7674774 Abuse-resistant amphetamine prodrugs
03/09/2010US7674769 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI)
03/09/2010US7674767 comprising 0.1-30 weight % complex of water-soluble drug and counter-ion substance in which charged water-soluble drug is bonded with counter-ion substance, 0.5-80 weight % lipid, 0.5-80 weight % polymer, and 1-80 weight % emulsifier; high gastrointestinal absorption rate; high drug entrapping rate
03/09/2010US7674623 Method of stabilizing human natriuretic peptides
03/09/2010US7674482 for producing acetylcholine and serotonin; improved cognitive function, induced and maintained sleep, reduced pain, inflammation, blood pressure, anxiety, asthma, duration of viral infection, insulin resistance, appetite, and treating depression
03/09/2010US7674476 Use of aerogels in agriculture
03/09/2010US7674475 Mixture of moxidectin, praziquantel, benzyl alcohol, ethanol, colloidal silica, surfactants and oil; veterinary medicine
03/09/2010US7674471 Topical composition, topical composition precursor, and methods for manufacturing and using
03/09/2010US7674470 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
03/09/2010US7674457 treating neurodegenerative disorders by administering a human umbilical cord blood and mannitol blood brain barrier permeabilizer; biodrug treating cerebral ischemia; cells are selected from all different organs
03/09/2010US7674454 Enzyme-prodrug therapy for prosthetic joint repair
03/09/2010US7674250 Methods of delivering therapeutic agents
03/09/2010CA2534268C Thermosensitive poly (organophosphazenes), preparation method thereof and injectable thermosensitive polyphosphazene hydrogels using the same
03/09/2010CA2472449C Pharmaceutical composition for oral use with improved absorption
03/09/2010CA2462457C Sanitary napkins with hydrophobic lotions
03/09/2010CA2432279C Preparation of microparticles having improved flowability
03/09/2010CA2424346C Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
03/09/2010CA2420495C A novel cationic lipopolymer as biocompatible gene delivery agent
03/09/2010CA2411922C Composition for pain mediation and apparatus and method of use thereof
03/09/2010CA2388395C Compound
03/09/2010CA2349696C Controlled release formulation for water soluble drugs
03/04/2010WO2010025324A2 Nanoparticles for immunotherapy
03/04/2010WO2010025322A2 Magnetic nanodelivery of therapeutic agents across the blood brain barrier
03/04/2010WO2010025176A2 Mcp-1 delivery system
03/04/2010WO2010024262A1 Transfection agent
03/04/2010WO2010023908A1 Nanocapsules containing indomethacin and manufacturing method therefor
03/04/2010WO2010023874A1 Film preparation containing loperamide hydrochloride
03/04/2010WO2010023689A2 Microparticles
03/04/2010WO2010023670A2 Methods for covalently attaching a polymer to a methionine residue in proteins and peptides
03/04/2010WO2010023321A1 Liquid formulation containing a taxane derivative
03/04/2010WO2010022525A1 Emulsion preconcentrates and micellar formulations comprising glyceryl fatty acid esters
03/04/2010WO2010022524A1 Emulsion preconcentrates, and micellar formulations comprising cyclodextrin
03/04/2010WO2010003691A3 BIOCONJUGATES COMPRISING Aβ-AUTOANTIBODY SPECIFIC EPITOPES FOR ACTIVE IMMUNOTHERAPY AND DIAGNOSIS OF ALZHEIMER'S DISEASE
03/04/2010WO2009152597A3 Topical use composition for combatting ectoparasites in dogs and cats
03/04/2010WO2009152144A3 All day rhinitic condition treatment regimen
03/04/2010WO2009151687A3 Dendrimer conjugates
03/04/2010WO2009149955A3 Method for the selection of a suitable adjuvant for the production of solid dispersions for pharmaceutical formulations
03/04/2010WO2009148245A3 Novel niacin and hmg-coa reductase inhibitor combination formulation
03/04/2010WO2009144712A8 Pediculicide compositions
03/04/2010WO2009141170A3 Compounds suited as nanocarriers for active agents and their use
03/04/2010WO2009140432A3 Micelles for intracellular delivery of therapeutic agents
03/04/2010WO2009140131A3 Compliant composites for application of drug-eluting coatings to tissue surfaces
03/04/2010WO2009129491A3 Beta adrenergic receptor agonists for treatment of pain and/or inflammation
03/04/2010WO2009129147A4 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
03/04/2010WO2009114520A9 Compositions for treatment with metallopeptidases, methods of making and using the same
03/04/2010WO2009095057A3 Transdermal therapeutic system having urea components
03/04/2010WO2009081287A3 Polysaccharide nanoparticles
03/04/2010WO2009046294A3 Treatment of proliferative disorders using antibodies to psma
03/04/2010WO2009043049A3 Pharmaceutical formulations
03/04/2010WO2009040811A3 Polymer nanoparticles coated by magnetic metal oxide and uses thereof
03/04/2010WO2009023955A8 Cytotoxicity mediation of cells evidencing surface expression of cd9
03/04/2010WO2008103044A8 Non-natural recombinant gelatins with enhanced functionality
03/04/2010US20100056646 Hydroswellable, segmented, aliphatic polyurethane ureas and intra-articular devices therefrom
03/04/2010US20100056537 Pharmaceutical composition having relatively low ionic strength
03/04/2010US20100056488 Corticosteroid conjugates and uses thereof
03/04/2010US20100056476 Pharmaceutical compositions comprising peranhydrocyclodextrin
03/04/2010US20100056453 Liquid, Aqueous Pharmaceutical Compositions of Factor VII Polypeptides
03/04/2010US20100056425 Absorption enhancers such as E.G. BHT, BHA or propyl gallate
03/04/2010US20100055265 Compound consisting of precipitated silica and phosphate and use thereof as nutrient intake liquid support and as anticaking agent with nutrient intake
03/04/2010US20100055191 Powder composition, method for producing the same, and food composition, cosmetic composition and pharmaceutical composition containing the same
03/04/2010US20100055180 Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
03/04/2010US20100055175 Soft gelatin capsule shells containing oil soluble flavoring and methods of making the same
03/04/2010US20100055168 Cationic lipids and uses thereof
03/04/2010US20100055160 Analgesic anti-inflammatory patches for topical use
03/04/2010US20100055159 Percutaneous preparations
03/04/2010US20100055156 Composition for the topical transmission of active ingredients into the human or animal body
03/04/2010US20100055153 Multipurpose hydrogel compositions and products
03/04/2010US20100055142 Carrier Neutralization/Modification in Antimicrobial Compositions, Articles and Methods
03/04/2010US20100055129 Modulators of myc, methods of using the same, and methods of indentifiying agents that modulate myc
03/04/2010US20100055115 Compositions and methods for stem cell delivery
03/04/2010US20100055097 Stable lyophilized pharmaceutical formulation of igg antibodies
03/04/2010US20100055068 Grafted polymers and uses thereof
1 ... 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 ... 1712